{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:04:55Z","timestamp":1786964695088,"version":"build-2736575974"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tuberous sclerosis complex (TSC) is a genetic multiorgan disorder characterized by the development of neoplastic lesions in kidney, lung, brain, heart, and skin. It is caused by an inactivating mutation in tumor suppressor genes coding the TSC1\/TSC2 complex, resulting in the hyperactivation of mTOR- and Raf\/MEK\/MAPK\u2013dependent signaling that stimulates tumor cell proliferation and metastasis. Despite its oncogenic effect, cells with TSC deficiency were more sensitive to oxidative stress and dependent on mitochondrial metabolism, providing a rationale for a new therapeutic approach. The current study shows that simultaneous inhibition of two major pathways regulating redox homeostasis using l-buthionine-sulfoximine (BSO, glutathione synthesis inhibitor) and auranofin (thioredoxin reductase inhibitor) induces oxidative burst, mitochondrial damage, and necrotic cell death in TSC-deficient cells in a highly synergistic and cell context\u2013specific manner. Furthermore, blocking RIP1\/RIP3\/MLKL\u2013dependent signaling using chemical inhibitors necrostatin-1 (Nec-1) and necrosulfonamide (NSA) synergizes with BSO and auranofin in killing TSC-deficient cells. Expression analysis demonstrated that RIP1, RIP3, and MLKL protein levels are elevated in cells with TSC2 deficiency, and their inactivation enhances mitochondrial dysfunction in a glutaminolysis-dependent and autophagy-independent manner. Finally, supplementation with the mitochondrial metabolite \u03b1-ketoglutarate, whose synthesis is regulated by RIP1\/RIP3\/MLKL, rescues cells from the sensitizing effect of Nec-1 and NSA. Together, this study identifies a previously unrecognized novel regulated necrotic death pathway that involves mitochondrial homeostasis, is suppressed by the RIP1\/RIP3\/MLKL signaling in TSC-deficient cells, and could be a promising therapeutic target for TSC-associated tumors. Cancer Res; 76(24); 7130\u20139. \u00a92016 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-16-1052","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T23:44:49Z","timestamp":1476834289000},"page":"7130-7139","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["TSC2 Deficiency Unmasks a Novel Necrosis Pathway That Is Suppressed by the RIP1\/RIP3\/MLKL Signaling Cascade"],"prefix":"10.1158","volume":"76","author":[{"given":"Piotr T.","family":"Filipczak","sequence":"first","affiliation":[{"name":"1Lovelace Respiratory Research Institute, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Thomas","sequence":"additional","affiliation":[{"name":"1Lovelace Respiratory Research Institute, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshu","family":"Chen","sequence":"additional","affiliation":[{"name":"1Lovelace Respiratory Research Institute, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Salzman","sequence":"additional","affiliation":[{"name":"2Radical Therapeutics, West Tisbury, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"McDonald","sequence":"additional","affiliation":[{"name":"1Lovelace Respiratory Research Institute, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lin","sequence":"additional","affiliation":[{"name":"1Lovelace Respiratory Research Institute, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Belinsky","sequence":"additional","affiliation":[{"name":"1Lovelace Respiratory Research Institute, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2016,12,15]]},"reference":[{"key":"2022061706062023300_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.pediatrneurol.2013.12.002","article-title":"Mechanism-based treatment in tuberous sclerosis complex","volume":"50","author":"J\u00fclich","year":"2014","journal-title":"Pediatr Neurol"},{"key":"2022061706062023300_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1542\/peds.2010-0192","article-title":"Tuberous sclerosis complex: diagnostic challenges presenting symptoms and commonly missed signs","volume":"127","author":"Staley","year":"2011","journal-title":"Pediatrics"},{"key":"2022061706062023300_bib3","first-page":"139","article-title":"Brain lesions in tuberous sclerosis complex","volume":"48","author":"Grajkowska","year":"2010","journal-title":"Rev Folia Neuropathol"},{"key":"2022061706062023300_bib4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2022061706062023300_bib5","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI58709","article-title":"Lymphangioleiomyomatosis - a wolf in sheep's clothing","volume":"122","author":"Henske","year":"2012","journal-title":"J Clin Invest"},{"key":"2022061706062023300_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-4632.2010.04727.x","article-title":"Tuberous sclerosis complex: tumors and tumorigenesis","volume":"50","author":"Borkowska","year":"2011","journal-title":"Int J Dermatol"},{"key":"2022061706062023300_bib7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00381-011-1488-8","article-title":"Neurosurgical treatment of tuberous sclerosis complex lesions","volume":"27","author":"Pascual-Castroviejo","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"2022061706062023300_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pediatrneurol.2012.02.015","article-title":"Emerging treatments in the management of tuberous sclerosis complex","volume":"46","author":"Kohrman","year":"2012","journal-title":"Pediatr Neurol"},{"key":"2022061706062023300_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"2022061706062023300_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.hoc.2012.02.014","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer therapy","volume":"26","author":"Gomez-Pinillos","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"2022061706062023300_bib11","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061706062023300_bib12","doi-asserted-by":"crossref","first-page":"e1231","DOI":"10.1038\/cddis.2014.204","article-title":"Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells","volume":"5","author":"Sun","year":"2014","journal-title":"Cell Death Dis"},{"key":"2022061706062023300_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/CLEP.S50780","article-title":"Clinical features epidemiology and therapy of lymphangioleiomyomatosis","volume":"7","author":"Taveira-DaSilva","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2022061706062023300_bib14","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201405-0918OC","article-title":"Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis","volume":"190","author":"Yao","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2022061706062023300_bib15","doi-asserted-by":"crossref","first-page":"e23379","DOI":"10.1371\/journal.pone.0023379","article-title":"Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease","volume":"6","author":"Dabora","year":"2011","journal-title":"PLoS One"},{"key":"2022061706062023300_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s40265-016-0552-9","article-title":"The role of mTOR inhibitors in the treatment of patients with tuberous sclerosis complex: evidence-based and expert opinions","volume":"76","author":"Curatolo","year":"2016","journal-title":"Drugs"},{"key":"2022061706062023300_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10549-013-2630-y","article-title":"Everolimus: side effect profile and management of toxicities in breast cancer","volume":"140","author":"Paplomata","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2022061706062023300_bib18","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1073\/pnas.1104361108","article-title":"Tumorigenesis in tuberous sclerosis complex is autophagy and p62\/sequestosome 1 (SQSTM1)- dependent","volume":"108","author":"Parkhitko","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706062023300_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1541-7786.MCR-13-0258-T","article-title":"Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide","volume":"12","author":"Parkhitko","year":"2013","journal-title":"Mol Cancer Res"},{"key":"2022061706062023300_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/1541-7786.MCR-14-0440","article-title":"High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null setting","volume":"13","author":"Medvetz","year":"2014","journal-title":"Mol Cancer Res"},{"key":"2022061706062023300_bib21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni.3206","article-title":"The diverse role of RIP kinases in necroptosis and inflammation","volume":"16","author":"Silke","year":"2015","journal-title":"Nat Immunol"},{"key":"2022061706062023300_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10616-013-9545-7","article-title":"Mouse cell line authentication","volume":"66","author":"Almeida","year":"2014","journal-title":"Cytotechnology"},{"key":"2022061706062023300_bib23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/CAD.0000000000000109","article-title":"Oxidative stress cell cycle arrest and differentiation contribute toward the antiproliferative action of BSO and calcitriol on Caco-2 cells","volume":"25","author":"Liaudat","year":"2014","journal-title":"Anticancer Drugs"},{"key":"2022061706062023300_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2202-6-10","article-title":"The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO)","volume":"6","author":"Chen","year":"2005","journal-title":"BMC Neurosci"},{"key":"2022061706062023300_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","article-title":"Auranofin: repurposing an old drug for a golden new age","volume":"15","author":"Roder","year":"2015","journal-title":"Drugs R D"},{"key":"2022061706062023300_bib26","doi-asserted-by":"crossref","first-page":"36505","DOI":"10.18632\/oncotarget.5364","article-title":"Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer","volume":"6","author":"Zou","year":"2015","journal-title":"Oncotarget"},{"key":"2022061706062023300_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.1172308","article-title":"RIP3 an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis","volume":"325","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"2022061706062023300_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.molcel.2010.05.007","article-title":"Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply","volume":"38","author":"Choo","year":"2010","journal-title":"Mol Cell"},{"key":"2022061706062023300_bib29","doi-asserted-by":"crossref","first-page":"26802","DOI":"10.1038\/srep26802","article-title":"Alpha-ketoglutarate promotes skeletal muscle hypertrophy and protein synthesis through Akt\/mTOR signaling pathways","volume":"6","author":"Cai","year":"2016","journal-title":"Sci Rep"},{"key":"2022061706062023300_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.4161\/auto.28235","article-title":"Dimethyl \u03b1- ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy","volume":"10","author":"Mari\u00f1o","year":"2014","journal-title":"Autophagy"},{"key":"2022061706062023300_bib31","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1523\/JNEUROSCI.0778-09.2009","article-title":"Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner","volume":"29","author":"Di Nardo","year":"2009","journal-title":"J Neurosci"},{"key":"2022061706062023300_bib32","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1242\/jcs.03199","article-title":"Increased Rheb-TOR signaling enhances sensitivity of the whole organism to oxidative stress","volume":"119","author":"Patel","year":"2006","journal-title":"J Cell Sci"},{"key":"2022061706062023300_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-4598-8-13","article-title":"Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients","volume":"8","author":"Habib","year":"2009","journal-title":"Mol Cancer"},{"key":"2022061706062023300_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40478-015-0225-z","article-title":"Tuberous sclerosis complex neuropathology requires glutamate- cysteine ligase","volume":"3","author":"Malik","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"2022061706062023300_bib35","doi-asserted-by":"crossref","first-page":"130185","DOI":"10.1098\/rsob.130185","article-title":"Rheb and mammalian target of rapamycin in mitochondrial homeostasis","volume":"3","author":"Groenewoud","year":"2013","journal-title":"Open Biol"},{"key":"2022061706062023300_bib36","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.1196371","article-title":"Phosphorylation of ULK1 (hATG1) by AMP activated protein kinase connects energy sensing to mitophagy","volume":"331","author":"Egan","year":"2001","journal-title":"Science"},{"key":"2022061706062023300_bib37","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nature06322","article-title":"mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex","volume":"450","author":"Cunningham","year":"2007","journal-title":"Nature"},{"key":"2022061706062023300_bib38","doi-asserted-by":"crossref","first-page":"e48175","DOI":"10.1371\/journal.pone.0048175","article-title":"Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism","volume":"7","author":"Sobhakumari","year":"2012","journal-title":"PLoS One"},{"key":"2022061706062023300_bib39","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1158\/1078-0432.CCR-11-0736","article-title":"Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism","volume":"17","author":"Fath","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2022061706062023300_bib40","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00018-010-0283-0","article-title":"Tumor necrosis factor-mediated cell death: to break or to burst that's the question","volume":"67","author":"Van Herreweghe","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"2022061706062023300_bib41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature10400","article-title":"Caspase-8 regulates TNF-\u03b1-induced epithelial necroptosis and terminal ileitis","volume":"477","author":"G\u00fcnther","year":"2011","journal-title":"Nature"},{"key":"2022061706062023300_bib42","first-page":"189","article-title":"Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia\/reperfusion injury","volume":"8","author":"Xu","year":"2010","journal-title":"Brain Res"},{"key":"2022061706062023300_bib43","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/carcin\/bgt143","article-title":"RIP1 potentiates BPDE-induced transformation in human bronchial epithelial cells through catalase-mediated suppression of excessive reactive oxygen species","volume":"34","author":"Wang","year":"2013","journal-title":"Carcinogenesis"},{"key":"2022061706062023300_bib44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/cdd.2014.25","article-title":"RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1\u03b1-mediated mitochondrial oxidative phosphorylation and glycolysis","volume":"21","author":"Chen","year":"2014","journal-title":"Cell Death Differ"},{"key":"2022061706062023300_bib45","doi-asserted-by":"crossref","first-page":"700","DOI":"10.15252\/embr.201439496","article-title":"RIP1 negatively regulates basal autophagic flux through TFEB to control sensitivity to apoptosis","volume":"16","author":"Yonekawa","year":"2015","journal-title":"EMBO Rep"},{"key":"2022061706062023300_bib46","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0006-291X(90)91544-3","article-title":"Chelerythrine is a potent and specific inhibitor of protein kinase C","volume":"172","author":"Herbert","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2022061706062023300_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/cdd.2012.151","article-title":"Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models","volume":"20","author":"Vandenabeele","year":"2013","journal-title":"Cell Death Differ"},{"key":"2022061706062023300_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cytogfr.2013.12.013","article-title":"Necrosis-dependent and independent signaling of the RIP kinases in inflammation","volume":"25","author":"Moriwaki","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"2022061706062023300_bib49","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2015.447","article-title":"Glutaminolysis as a target for cancer therapy","volume":"35","author":"Jin","year":"2016","journal-title":"Oncogene"},{"key":"2022061706062023300_bib50","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.aab4082","article-title":"Somatic mutation in cancer and normal cells","volume":"349","author":"Martincorena","year":"2015","journal-title":"Science"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/24\/7130\/2744801\/7130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/24\/7130\/2744801\/7130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:41:20Z","timestamp":1655473280000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/76\/24\/7130\/616073\/TSC2-Deficiency-Unmasks-a-Novel-Necrosis-Pathway"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,15]]},"references-count":50,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2016,12,15]]},"published-print":{"date-parts":[[2016,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-16-1052","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22413144.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508632","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413141","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508632.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413153.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413141.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413144","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413153","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413147.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413147","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,15]]}}}